Literature DB >> 28262214

Hospital Management of Acute Decompensated Heart Failure.

Ashraf S Abdo1.   

Abstract

Heart failure (HF) is one of the leading causes of hospitalizations for elderly adults in the United States. One in 5 Americans will be >65 years of age by 2050. Because of the high prevalence of HF in this group, the number of Americans requiring hospitalization for this disorder is expected to rise significantly. We reviewed the most recent and ongoing studies and recommendations for the management of patients hospitalized due to decompensated HF. The Acute Decompensated Heart Failure National Registry, together with the 2013 American College of Cardiology Foundation and American Heart Association heart failure guidelines, earlier retrospective and prospective studies including the Diuretic Optimization Strategies Evaluation (DOSE), the Trial of Intensified vs Standard Medical Therapy in the Elderly Patients With Congestive Heart Failure (TIME-CHF), the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF), the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) and the Comparison of Medical, Pacing and Defibrillation Therapies in Heart Failure (COMPANION) trial were reviewed for current practices pertaining to these patients. Gaps in our knowledge of optimal use of patient-specific information (biomarkers and comorbid conditions) still exist. Published by Elsevier Inc.

Entities:  

Keywords:  Diagnosis and therapy; Heart failure; Inpatient management

Mesh:

Year:  2016        PMID: 28262214     DOI: 10.1016/j.amjms.2016.08.026

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Prevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure: The ARIC Study.

Authors:  Sameer Arora; Krishan Sivaraj; Michael Hendrickson; Patricia P Chang; Thelsa Weickert; Arman Qamar; Muthiah Vaduganathan; Melissa C Caughey; Ambarish Pandey; Matthew A Cavender; Wayne Rosamond; John P Vavalle
Journal:  JACC Heart Fail       Date:  2020-12-09       Impact factor: 12.035

2.  Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure.

Authors:  Takumi Noda; Kentaro Kamiya; Nobuaki Hamazaki; Kohei Nozaki; Takafumi Ichikawa; Takeshi Nakamura; Masashi Yamashita; Shota Uchida; Emi Maekawa; Jennifer L Reed; Minako Yamaoka-Tojo; Atsuhiko Matsunaga; Junya Ako
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

3.  Trial of Oral Diuretics Prior to Discharge Is Not Associated With Improved Outcomes in Decompensated Heart Failure.

Authors:  Adeba Mohammad; Shuktika Nandkeolyar; Dennis Grewal; Antoine Sakr; Ahmed Seliem; Liset Stoletniy; Dmitry Abramov
Journal:  Cardiol Res       Date:  2021-07-09

4.  Diagnostic and prognostic significance of aberrant miR-652-3p levels in patients with acute decompensated heart failure and acute kidney injury.

Authors:  Jiaolei Liu; Hongmei Zhang; Xin Li; Lin Wang; Huining Yu; Jiaohong Huang; Qingjun Liu; Chao Wang; Aili Jiang
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

5.  MiR-125b inhibits cardiomyocyte apoptosis by targeting BAK1 in heart failure.

Authors:  Bei Zhang; Shanyong Mao; Xingde Liu; Sha Li; Haiyan Zhou; Ying Gu; Wupeng Liu; Lei Fu; Chunyan Liao; Pengzhen Wang
Journal:  Mol Med       Date:  2021-07-08       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.